ATE299881T1 - 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren - Google Patents
4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitorenInfo
- Publication number
- ATE299881T1 ATE299881T1 AT00990229T AT00990229T ATE299881T1 AT E299881 T1 ATE299881 T1 AT E299881T1 AT 00990229 T AT00990229 T AT 00990229T AT 00990229 T AT00990229 T AT 00990229T AT E299881 T1 ATE299881 T1 AT E299881T1
- Authority
- AT
- Austria
- Prior art keywords
- indolin
- aza
- substituted
- application
- protein kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17128899P | 1999-12-21 | 1999-12-21 | |
PCT/US2000/034259 WO2001046196A1 (en) | 1999-12-21 | 2000-12-21 | 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE299881T1 true ATE299881T1 (de) | 2005-08-15 |
Family
ID=22623214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00990229T ATE299881T1 (de) | 1999-12-21 | 2000-12-21 | 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren |
Country Status (11)
Country | Link |
---|---|
US (2) | US6610688B2 (de) |
EP (1) | EP1244672B1 (de) |
JP (1) | JP2003518123A (de) |
AR (1) | AR029423A1 (de) |
AT (1) | ATE299881T1 (de) |
AU (1) | AU2728201A (de) |
CA (1) | CA2395520A1 (de) |
CO (1) | CO5271715A1 (de) |
DE (1) | DE60021423T2 (de) |
ES (1) | ES2245955T3 (de) |
WO (1) | WO2001046196A1 (de) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6987113B2 (en) | 1997-06-11 | 2006-01-17 | Sugen, Inc. | Tyrosine kinase inhibitors |
WO2000012084A1 (en) | 1998-08-31 | 2000-03-09 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
AR039241A1 (es) | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
UA80295C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
US20050043212A1 (en) * | 2002-10-09 | 2005-02-24 | Ford Kirschenbaum | Differential inhibition of p38 map kinase isoforms |
WO2004032874A2 (en) * | 2002-10-09 | 2004-04-22 | Scios Inc. | AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE |
US20050288299A1 (en) * | 2002-10-09 | 2005-12-29 | Mavunkel Babu J | Azaindole derivatives as inhibitors of p38 kinase |
CN102358738A (zh) | 2003-07-30 | 2012-02-22 | 里格尔药品股份有限公司 | 2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途 |
US7338957B2 (en) * | 2003-08-28 | 2008-03-04 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
BRPI0414533A (pt) | 2003-09-18 | 2006-11-07 | Conforma Therapeutics Corp | composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90 |
US20050203111A1 (en) * | 2004-03-12 | 2005-09-15 | Vvii Newco 2003, Inc. | Compositions and methods for preventing and treating skin and hair conditions |
CA2558439A1 (en) * | 2004-03-11 | 2005-10-06 | Kythera Biopharmaceuticals, Inc. | Compositions and methods for preventing and treating skin and hair conditions |
US20060058339A1 (en) * | 2004-06-17 | 2006-03-16 | Ibrahim Prabha N | Compounds modulating c-kit activity and uses therefor |
MY179032A (en) | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
JP4935357B2 (ja) * | 2004-11-08 | 2012-05-23 | Msd株式会社 | 新規縮環イミダゾール誘導体 |
WO2006133426A2 (en) | 2005-06-08 | 2006-12-14 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
US20070203161A1 (en) * | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
US7560551B2 (en) | 2006-01-23 | 2009-07-14 | Amgen Inc. | Aurora kinase modulators and method of use |
WO2007085188A1 (en) | 2006-01-27 | 2007-08-02 | Shanghai Hengrui Pharmaceutical Co. Ltd. | Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors |
CN101007815B (zh) * | 2006-01-27 | 2010-06-23 | 江苏恒瑞医药股份有限公司 | 吡咯并六元杂环化合物及其在医药上的用途 |
CA2642229C (en) | 2006-02-24 | 2015-05-12 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
MX2008012860A (es) * | 2006-04-05 | 2009-01-07 | Vertex Pharma | Desazapurinas de utilidad como inhibidores de janus cinasas. |
CN101054379A (zh) * | 2006-04-11 | 2007-10-17 | 上海恒瑞医药有限公司 | 吡咯取代的嘧啶酮衍生物、其制备方法及其在医药上的用途 |
GB0608176D0 (en) * | 2006-04-25 | 2006-06-07 | Astex Therapeutics Ltd | Pharmaceutical Compounds |
JP5606734B2 (ja) * | 2006-04-25 | 2014-10-15 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
AU2007245495A1 (en) | 2006-04-26 | 2007-11-08 | Astex Therapeutics Limited | Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds |
CA2858520A1 (en) | 2006-05-18 | 2007-11-29 | Pharmacyclics Inc. | Intracellular kinase inhibitors |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
US20100173426A1 (en) * | 2006-12-19 | 2010-07-08 | Johnson Faye M | Biomaker identifying the reactivation of stat3 after src inhibition |
EP2125895B1 (de) * | 2007-02-02 | 2015-04-08 | Vegenics Pty Ltd | Vegf-rezeptorantagonisten zur behandlung von allommunität bei organtransplantationen und atherosklerose |
US20100190777A1 (en) | 2007-07-17 | 2010-07-29 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
JP5511680B2 (ja) | 2007-12-19 | 2014-06-04 | キャンサー・リサーチ・テクノロジー・リミテッド | ピリド[2,3−b]ピラジン−8−置換化合物及びその使用 |
US20090203709A1 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor |
NZ587589A (en) * | 2008-02-15 | 2012-10-26 | Rigel Pharmaceuticals Inc | Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
US8138339B2 (en) | 2008-04-16 | 2012-03-20 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
NZ589315A (en) | 2008-04-16 | 2012-11-30 | Portola Pharm Inc | 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors |
EP2271631B1 (de) * | 2008-04-22 | 2018-07-04 | Portola Pharmaceuticals, Inc. | Inhibitoren von proteinkinasen |
GB0807609D0 (en) | 2008-04-25 | 2008-06-04 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
RU2505540C2 (ru) * | 2008-12-23 | 2014-01-27 | Эббви Инк. | Антивирусные соединения |
JP2012513410A (ja) | 2008-12-23 | 2012-06-14 | アボット・ラボラトリーズ | 抗ウイルス化合物 |
CR20170089A (es) | 2009-04-03 | 2017-07-17 | Plexxikon Inc | Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas |
MX2011010905A (es) * | 2009-04-15 | 2011-11-01 | Abbott Lab | Compuestos antivirales. |
JP5530514B2 (ja) | 2009-06-11 | 2014-06-25 | アッヴィ・バハマズ・リミテッド | Hcv感染を治療するための抗ウィルス化合物 |
US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
BR112012002001A2 (pt) * | 2009-07-28 | 2016-05-10 | Rigel Pharmaceuticals Inc | método para tratar uma doença e/ou distúrbio do olho, formulação farmacêutica, e, kit |
WO2011041584A2 (en) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
NZ599866A (en) | 2009-11-06 | 2014-09-26 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
PL2531502T3 (pl) | 2010-02-01 | 2014-08-29 | Cancer Research Tech Ltd | 1-(5-tert-Butylo-2-fenylo-2H-pirazol-3-ilo)-3-[2-fluoro-4-(1-metylo-2-okso-2,3-dihydro-1H-imidazo[4,5-b]pirydyn-7-yloksy)-fenylo]-mocznik i związki pokrewne oraz ich zastosowanie w terapii |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
EP2635557A2 (de) | 2010-11-01 | 2013-09-11 | Portola Pharmaceuticals, Inc. | Nicotinamide als jak-kinasemodulatoren |
LT2654750T (lt) * | 2010-12-20 | 2017-05-10 | Pfizer Inc. | Nauji kondensuoti piridino junginiai, kaip kazeino kinazės inhibitoriai |
US9943605B2 (en) | 2010-12-23 | 2018-04-17 | Nektar Therapeutics | Polymer-semaxanib moiety conjugates |
MA34948B1 (fr) | 2011-02-07 | 2014-03-01 | Plexxikon Inc | Composes et procedes de modulation de kinase, et leurs indications |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
US20140113824A1 (en) | 2011-05-10 | 2014-04-24 | Bayer Intellectual Property Gmbh | Bicyclic (thio)carbonylamidines |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
IN2014CN04065A (de) | 2011-11-23 | 2015-09-04 | Portola Pharm Inc | |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
WO2013162027A1 (ja) | 2012-04-27 | 2013-10-31 | 学校法人 慶應義塾 | 神経分化促進剤 |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
WO2014058921A2 (en) | 2012-10-08 | 2014-04-17 | Portola Pharmaceuticals, Inc. | Substituted pyrimidinyl kinase inhibitors |
US9925240B2 (en) | 2013-03-06 | 2018-03-27 | Genentech, Inc. | Methods of treating and preventing cancer drug resistance |
CN105408320B (zh) * | 2013-03-13 | 2019-08-13 | 北京强新生物科技有限公司 | 用于治疗癌症的作为癌症干细胞途径激酶抑制剂的3-(芳基或杂芳基)甲基吲哚-2-酮衍生物 |
US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
JP2017517552A (ja) | 2014-06-13 | 2017-06-29 | ジェネンテック, インコーポレイテッド | 抗癌剤耐性の治療及び防止方法 |
CN107801379B (zh) | 2015-06-16 | 2021-05-25 | 卫材R&D管理有限公司 | 抗癌剂 |
AU2016284383B2 (en) | 2015-06-23 | 2020-08-20 | Eisai R&D Management Co., Ltd. | Crystal of (6S,9aS)-N-benzyl-8-({6-[3-(4-ethylpiperazin-1- yl)azetidin-1-yl]pyridin-2-yl}methyl)-6-(2-fluoro-4- hydroxybenzyl)-4,7-dioxo-2-(prop-2-en-1-yl)hexahydro-2Hpyrazino[ 2,1-c][1,2,4]triazine-1-(6H)-carboxamide |
CA3004595A1 (en) * | 2015-11-12 | 2017-05-18 | Lg Chem, Ltd. | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof |
CN106008528A (zh) * | 2016-07-28 | 2016-10-12 | 安徽赛迪生物科技有限公司 | 一种合成4-氯-5,7-二氢-6h-吡咯并[2,3-d]嘧啶-6-酮的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0257102B1 (de) | 1986-02-24 | 1997-11-19 | Mitsui Petrochemical Industries, Ltd. | Mittel zur behandlung von neuropathie |
WO1991009598A1 (en) | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
US5811432A (en) | 1990-11-09 | 1998-09-22 | Pfizer Inc | Azaoxindole derivatives |
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
PL175327B1 (pl) * | 1992-04-03 | 1998-12-31 | Upjohn Co | Dwupierścieniowe heterocykliczne aminy |
MX9304769A (es) | 1992-08-05 | 1994-05-31 | Max Planck Gesellschaft | Subfamilia ptp-d de fosfatasas de la proteina tirosina. |
GB9423997D0 (en) | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
TR199900048T2 (xx) | 1996-07-13 | 1999-04-21 | Glaxo Group Limited | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler |
HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
BR9713552A (pt) | 1996-11-27 | 2000-01-25 | Pfizer | Derivados de pirimidina bicìclicos condensados |
GB9721437D0 (en) | 1997-10-10 | 1997-12-10 | Glaxo Group Ltd | Heteroaromatic compounds and their use in medicine |
JPH11209350A (ja) | 1998-01-26 | 1999-08-03 | Eisai Co Ltd | 含窒素複素環誘導体およびその医薬 |
WO2001064681A2 (en) * | 2000-02-28 | 2001-09-07 | Sugen, Inc. | 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
-
2000
- 2000-12-21 ES ES00990229T patent/ES2245955T3/es not_active Expired - Lifetime
- 2000-12-21 CA CA002395520A patent/CA2395520A1/en not_active Abandoned
- 2000-12-21 AR ARP000106848A patent/AR029423A1/es unknown
- 2000-12-21 EP EP00990229A patent/EP1244672B1/de not_active Expired - Lifetime
- 2000-12-21 WO PCT/US2000/034259 patent/WO2001046196A1/en active IP Right Grant
- 2000-12-21 AU AU27282/01A patent/AU2728201A/en not_active Abandoned
- 2000-12-21 AT AT00990229T patent/ATE299881T1/de not_active IP Right Cessation
- 2000-12-21 CO CO00097184A patent/CO5271715A1/es not_active Application Discontinuation
- 2000-12-21 US US09/741,737 patent/US6610688B2/en not_active Expired - Fee Related
- 2000-12-21 DE DE60021423T patent/DE60021423T2/de not_active Expired - Fee Related
- 2000-12-21 JP JP2001547106A patent/JP2003518123A/ja not_active Withdrawn
-
2003
- 2003-07-21 US US10/622,787 patent/US6908930B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2395520A1 (en) | 2001-06-28 |
ES2245955T3 (es) | 2006-02-01 |
US20020183319A1 (en) | 2002-12-05 |
EP1244672B1 (de) | 2005-07-20 |
AU2728201A (en) | 2001-07-03 |
US6610688B2 (en) | 2003-08-26 |
CO5271715A1 (es) | 2003-04-30 |
AR029423A1 (es) | 2003-06-25 |
DE60021423T2 (de) | 2006-04-13 |
US20040053924A1 (en) | 2004-03-18 |
DE60021423D1 (de) | 2005-08-25 |
WO2001046196A1 (en) | 2001-06-28 |
JP2003518123A (ja) | 2003-06-03 |
EP1244672A1 (de) | 2002-10-02 |
US6908930B2 (en) | 2005-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE299881T1 (de) | 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren | |
DE60208661D1 (de) | Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren | |
DE69836346D1 (de) | Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer | |
DE60103974D1 (de) | Gyrase-inhibitoren und ihre verwendung | |
ATE268761T1 (de) | Substituierte quinazolin-derivate und ihre verwendung als tyrosin-kinase inhibitoren | |
DE60036803D1 (de) | Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel | |
ATE394102T1 (de) | Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren | |
DE60020100D1 (de) | Dimerverbindungen und als inhibitoren der neuramidinase | |
DE60030574D1 (de) | Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren | |
DE60139477D1 (de) | 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel | |
FR13C0003I2 (fr) | Inhibiteurs cycliques de proteine tyrosine kinase | |
NO20021820D0 (no) | Tyrosinkinaseinhibitorer | |
DE602004021037D1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
DE60044004D1 (de) | Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren | |
ATE255575T1 (de) | Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren | |
ATE309996T1 (de) | Chinolinonderivate als tyrosin-kinase inhibitoren | |
ATE521598T1 (de) | 5-phenylthiazol-derivate und ihre verwendung als pi3 kinase inhibitoren | |
ATE329906T1 (de) | Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren | |
ATE456657T1 (de) | Aromatische methyltransferasen und ihre verwendung | |
DE60112635D1 (de) | Ölzusammensetzung und ihre Verwendung | |
DE60037183D1 (de) | Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren | |
DE60302152D1 (de) | Diaminothiazole und ihre anwendung als cdk4 inhibitoren | |
DE60230162D1 (de) | Polymerisate und ihre verwendung | |
DE60102151D1 (de) | Neue thiochromanderivate und ihre verwendung als thrombininhibitoren | |
ATE253059T1 (de) | Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |